Har Adar, Israel

Hadas Reuveni

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Aminadav, IL (1999)
  • Yehuda, IL (2005)
  • D.N. Harei Yehuda, IL (2010)
  • Har Adar, IL (2011 - 2021)

Company Filing History:


Years Active: 1999-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Hadas Reuveni: Innovator in Cancer Treatment

Introduction

Hadas Reuveni is a prominent inventor based in Har Adar, Israel. She has made significant contributions to the field of cancer treatment, holding a total of 12 patents. Her innovative work focuses on developing therapies that address the challenges of tumor resistance to various cancer treatments.

Latest Patents

One of Hadas Reuveni's latest patents involves the use of combinations of Insulin Receptor Substrate (IRS) and signal transducer and activator of transcription 3 (Stat3) dual modulators alongside anti-cancer agents. This treatment aims to combat cancer by targeting tumors that have developed resistance to EGFR inhibitors, EGFR antibodies, mTOR inhibitors, MEK inhibitors, mutated B-Raf inhibitors, and chemotherapeutic agents. The patent also outlines methods to prevent acquired resistance and tumor recurrence after treatment cessation. Additionally, her work includes combination therapies that utilize IRS and Stat3 dual modulators in conjunction with immunotherapy agents to enhance tumor sensitivity to immunotherapy.

Career Highlights

Throughout her career, Hadas Reuveni has worked with notable organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Novotyr Therapeutics Ltd. Her research has significantly advanced the understanding and treatment of cancer.

Collaborations

Hadas has collaborated with esteemed colleagues such as Alexander Levitzki and Shmuel A Ben-Sasson, contributing to the development of innovative cancer therapies.

Conclusion

Hadas Reuveni's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. Her patents and collaborations highlight her commitment to advancing therapeutic options for patients facing challenging cancers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…